MORGAN STANLEY ASIA PRODUCTS/CALL/SINO BIOPHARMA/4.08/1/30.07.24 MORGAN STANLEY ASIA PRODUCTS/CALL/SINO BIOPHARMA/4.08/1/30.07.24 Share Price
Warrant
20885
CH0396406149
| Delayed Hong Kong S.E. 01:30:00 26/06/2024 pm IST | ||
| 0.013 HKD | 0.00% |
|
| 1 month | -50.00% | ||
| 3 months | -85.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about SINO BIOPHARMACEUTICAL LIMITED
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 0.013 | 0.00% |
| 25/24/25 | 0.013 | 0.00% |
| 24/24/24 | 0.013 | 0.00% |
| 21/24/21 | 0.013 | 0.00% |
| 20/24/20 | 0.013 | 0.00% |
Delayed Quote Hong Kong S.E.
Last update June 26, 2024 at 01:30 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | SINO BIOPHARMACEUTICAL LIMITED |
| Issuer | Morgan Stanley |
| 20885 | |
| ISIN | CH0396406149 |
| Date issued | 30/10/2023 |
| Strike | 4.08 $ |
| Maturity | 30/07/2024 (34 Days) |
| Parity | 1 : 1 |
| Emission price | 0.25 $ |
| Emission volume | N/A |
| Settlement | cash |
| Currency | HKD |
Technical Indicators
| Highest since issue | 0.56 $ |
|---|---|
| Lowest since issue | 0.013 $ |
| Spread | 0.003 $ |
| Spread % | 23.08% |
Company Profile
Sino Biopharmaceutical Limited specialises in the development, manufacture and marketing of biopharmaceutical products primarily for the treatment of cancer, ophthalmia, hepatitis, orthopedic diseases and respiratory disorders. Net sales break down by category of products as follows:
- chemical medicine products and biopharmaceutical drugs (97.6%);
- other (2.4%).
Sector
-
Ratings for Sino Biopharmaceutical Limited
Trading Rating
Investor Rating
ESG Refinitiv
B-
Consensus: Sino Biopharmaceutical Limited
Sell
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
2.568
CNY
Average target price
4.263
CNY
Spread / Average Target
+66.01%
- Stock Market
- Warrants
- 20885 Warrant
